Minnelide

N/A

Report date: 2022/08/29 20:00:24
NME

Base Information

Drug NameMinnelide
Drug Alias Name14-O-phosphonooxymethyltriptolide-disodium-saltMinnelide-001
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActiondCTP pyrophosphatase 1 inhibitorsHeat shock 70 kDa protein 1 inhibitors
TargetsHeat shock 70 kDa protein 1dCTP pyrophosphatase 1
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsPancreatic Neoplasms +[9] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSouth Korea
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMinneamrita Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesNational Cancer InstituteMinneamrita Therapeutics Llc
Inactive CompaniesH Lee Moffitt Cancer Center & Research Institute
Active IndicationsSolid tumoursProstatic NeoplasmsPancreatic Neoplasms +[6] 
Inactive IndicationsGastrointestinal NeoplasmsLeukemia, Myeloid, AcuteNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A